Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Minor version bump: v3.0.2 replaces v3.0.1 with no other content changes.
    Difference
    0.3%
    Check dated 2025-09-14T19:25:04.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T16:22:41.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related details have been removed.
    Difference
    4%
    Check dated 2025-08-31T12:04:53.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T04:33:58.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-08-10T00:27:01.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    4%
    Check dated 2025-08-01T18:48:57.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.